The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: Part 2. Behavioral and cognitive changes
Abstract
Alzheimer's disease (AD) is characterized by distinct behavioral and cognitive deficits that differ from those observed in normal aging. Transgenic models of AD are a promising tool in understanding the underlying mechanisms and cause of disease. The triple-transgenic mouse model of AD (3xTg-AD) is the only model to exhibit both Abeta and tau pathology that is characteristic of the human form. The present study characterized the performance of 3xTg-AD mice on several tasks measuring behavioral and cognitive ability. Aged 3xTg-AD females exhibited a higher level of fear and anxiety demonstrated by increased restlessness, startle responses, and freezing behaviors. No differences were observed in muscle strength and visuo-motor coordination. Understanding the behavioral manifestations that occur in this model of AD may aid in the early diagnosis and appropriate treatment of AD symptomology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here Aβ deposition has not altered hippocampal functioning and the animals do not display long term memory alterations (Sterniczuk et al., 2010).”
From Early stage alterations in white matter and decreased functional interhemispheric hippocampal connectivity in the 3xTg mouse model of Alzheimer’s disease. (2019) · cites this paper as Sterniczuk et al., 2010
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citationThe open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037/0033-2909.83.3.482 · Cited by 2,389
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Self-citationAttention and executive deficits in Alzheimer's disease: A critical review
Perry, R. J. (1999) · Brain · doi:10.1093/brain/122.3.383 · Cited by 1,252
Irwin, S. (1968) · Psychopharmacology · doi:10.1007/bf00401402 · Cited by 1,240
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease
Witting, W., Kwa, I. H., Eikelenboom, P., Mirmiran, M., & Swaab, D. F. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90523-5 · Cited by 621
Estrogen Replacement Therapy in Older Women
Henderson, V. W. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210068014 · Cited by 590
Cited by
Sorted by citations
Items 101–200 of 228
Espinosa‐Fernández, V., Mañas-Ojeda, A., Pacheco‐Herrero, M., Castro-Salazar, E., Ros‐Bernal, F., & Sánchez‐Pérez, A. M. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112106 · Cited by 25
Shen, L., Yang, A., Chen, X., Xiao, S., Liu, X., Lin, J., Zhao, Y., Zhang, K., Li, C., Ke, J., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01052-z · Cited by 24
Bories, C., Arsenault, D., Lemire, M., Tremblay, C., Koninck, Y. D., & Calon, F. (2017) · Aging · doi:10.18632/aging.101239 · Cited by 25
Deciphering Brain Function by Miniaturized Fluorescence Microscopy in Freely Behaving Animals
Malvaut, S., Constantinescu, V.-S., Dehez, H., Dorić, S., & Saghatelyan, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00819 · Cited by 22
Mitochondria exert age-divergent effects on recovery from spinal cord injury
Stewart, A. N., McFarlane, K. E., Vekaria, H. J., Bailey, W. M., Slone, S. A., Tranthem, L. A., Zhang, B., Patel, S. P., Sullivan, P. G., & Gensel, J. C. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113597 · Cited by 23
Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation
Park, J., Choi, H., Kim, Y. D., Kim, S.-H., Kim, Y., Gwon, Y., Lee, D. Y., Park, S., Heo, W. D., & Jung, Y. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-01003-y · Cited by 23
Ye, M., Chung, H., An, Y. H., Lim, S.-J., Choi, W., Yu, A., Kim, J. S., Kang, M., Cho, S., Shim, I., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9458-x · Cited by 22
Age-related neuropsychiatric symptoms in presenilins conditional double knockout mice
Li, Y., Li, L., Han, W., Pan, B., Xue, X., & Mei, B. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.06.002 · Cited by 24
Saber, M., Murphy, S. M., Cho, Y., Lifshitz, J., & Rowe, R. K. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24771 · Cited by 21
Roy, A., Sharma, S., Nag, T. C., Katyal, J., Gupta, Y. K., & Jain, S. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00563-x · Cited by 20
Torres–Lista, V., & Giménez‐Llort, L. (2015) · Behavioural Processes · doi:10.1016/j.beproc.2015.09.011 · Cited by 22
Evaluation of attention in APP/PS1 mice shows impulsive and compulsive behaviours
Shepherd, A. L., May, C., Churilov, L. P., Adlard, P. A., Hannan, A. J., & Burrows, E. L. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12594 · Cited by 24
Le, M. H., Weissmiller, A. M., Monte, L., Lin, P. H., Hexom, T. C., Natera-Naranjo, O., Wu, C., & Rissman, R. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147250 · Cited by 21
Commins, S., & Kirby, B. P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104363 · Cited by 22
Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
Mitrano, D. A., Houle, S., Pearce, P., Quintanilla, R. M., Lockhart, B. K., Genovese, B. C., Schendzielos, R., Croushore, E. E., Dymond, E. M., Bogenpohl, J. W., et al. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2020.12.004 · Cited by 21
Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer’s Disease in Mice
Nazir, S., Anwar, F., Saleem, U., Ahmad, B., Raza, Z., Sanawar, M., Rehman, A. U., & Ismail, T. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03327-9 · Cited by 22
Batista, A., Guimarães, P., Martins, J., Moreira, P. I., Ambrósio, A. F., Castelo-Branco, M. S., Serranho, P., & Bernardes, R. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1161847 · Cited by 22
Yao, X., Xian, X., Fang, M., Fan, S., & Li, W. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00365 · Cited by 21
Reyna, N. C., Clark, B. J., Hamilton, D. A., & Pentkowski, N. S. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1251075 · Cited by 21
Nagy, P. M., & Aubert, I. (2013) · Brain and Behavior · doi:10.1002/brb3.139 · Cited by 21
Muntsant-Soria, A., & Giménez‐Llort, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070715 · Cited by 21
Virgili, J., Lebbadi, M., Tremblay, C., St‐Amour, I., Pierrisnard, C., Faucher-Genest, A., Émond, V., Julien, C., & Calon, F. (2018) · Synapse · doi:10.1002/syn.22025 · Cited by 22
Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer’s Disease
Dionisio-Santos, D. A., Behrouzi, A., Olschowka, J. A., & O’Banion, M. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00441 · Cited by 20
Arsenault, D., Tremblay, C., Émond, V., & Calon, F. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00337-0 · Cited by 19
Muntsant-Soria, A., & Giménez‐Llort, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.969381 · Cited by 19
Drechsler, S., Lynch, M. A., Novella, S., Navarro, H. G., Hecimovic, S. K., Barini, E., Tucci, V., Castro, R. E., Vandenbroucke, R. E., Osuchowski, M. F., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.07.005 · Cited by 20
Chakraborty, S., Chen, S.-T., Hsiao, Y.-T., Chiu, M., & Sun, C. (2019) · Biomedical Optics Express · doi:10.1364/boe.378447 · Cited by 17
Dong, Z. H., Li, Y., Huang, G. J., Zhang, L., Mei, B., & Meng, B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.048 · Cited by 18
Ho, A., Ngala, B., Yamada, C., Garcia, C., Duarte, C. L., Akkaoui, J., Ciolac, D., Nusbaum, A., Kochen, W. R., Efremova, D., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115435 · Cited by 15
Zhang, N., Sui, Y., Jendrichovsky, P., Feng, H., Shi, H., Zhang, X., Xu, S., Sun, W., Zhang, H., Chen, X., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01472-1 · Cited by 25
Persistence of behaviours in the Forced Swim Test in 3xTg-AD mice at advanced stages of disease
Torres–Lista, V., & Giménez‐Llort, L. (2014) · Behavioural Processes · doi:10.1016/j.beproc.2014.05.001 · Cited by 16
Setogawa, S., YAMAURA, H., Arasaki, T., Endo, S., & Yanagihara, D. (2014) · Scientific Reports · doi:10.1038/srep07220 · Cited by 15
Role of mitogen-activated protein kinase inhibitors in Alzheimer's disease: Rouge of brain kinases
Almasoudi, S. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Eliwa, D., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111296 · Cited by 16
Reis, R. J. S., Ayyadevara, S., Ganne, A., Mainali, N., Balasubramaniam, M., Atluri, R., Pahal, S., Asante, J., Nagel, C., & Vallurupalli, S. (2024) · doi:10.59368/agingbio.20240028 · Cited by 14
Boggs, K. N., Kakalec, P. A., Smith, M. L., Howell, S., & Flinn, J. M. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.09.021 · Cited by 13
Kapadia, M., Mian, M. F., Ma, D., Hutton, C. P., Azam, A., Narkaj, K., Cao, C., Brown, B., Michalski, B., Morgan, D., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00745-9 · Cited by 14
Hutton, C. P., Lemon, J. A., Šakić, B., Rollo, C. D., Boreham, D. R., Fahnestock, M. L., Wojtowicz, J. M., & Becker, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170921 · Cited by 15
Taxier, L. R., Philippi, S. M., York, J. M., LaDu, M. J., & Frick, K. M. (2022) · Hormones and Behavior · doi:10.1016/j.yhbeh.2022.105124 · Cited by 13
Landry, O., François, A., Mi-mba, M.-F. O. M., Traversy, M.-T., Tremblay, C., Émond, V., Bennett, D. A., Gylys, K. H., Buxbaum, J. D., & Calon, F. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1945-22.2023 · Cited by 14
Retinal Biomarkers of Alzheimer’s Disease: Insights from Transgenic Mouse Models
Bernardes, R., da Silva, G. T. R., Chiquita, S., Serranho, P., & Ambrósio, A. F. (2017) · Lecture notes in computer science · doi:10.1007/978-3-319-59876-5_60 · Cited by 13
Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer’s Disease
Yang, E., Wang, J., Woodie, L. N., Greene, M. W., & Kaddoumi, A. (2023) · Molecules · doi:10.3390/molecules28145592 · Cited by 12
Muntsant-Soria, A., Castillo-Ruiz, M. D. M., & Giménez‐Llort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813796 · Cited by 14
Özcan, G. G., Lim, S., Canning, T., Tirathdas, L., Donnelly, J., Kundu, T., & Rihel, J. (2024) · iScience · doi:10.1016/j.isci.2024.108870 · Cited by 12
Mesenchymal Stem Cells: New Alternatives for Nervous System Disorders
Jiménez-Acosta, M. A., Rochín-Hernández, L. J., Padilla-Cristerna, M. L., & Meraz‐Ríos, M. A. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220511153133 · Cited by 12
Temporal Appearance of Enhanced Innate Anxiety in Alzheimer Model Mice
Szabó, A., Farkas, S., Fazekas, C. L., Correia, P., Chaves, T., Sipos, E., Makkai, B., Török, B., & Zelena, D. (2023) · Biomedicines · doi:10.3390/biomedicines11020262 · Cited by 12
Maglione, A., do Nascimento, B. P. P., Ribeiro, M. O., de Souza, T. J. L., da Silva, R. E. C., Sato, M. A., Penatti, C. A. A., Britto, L. R., de Souza, J. S., Maciel, R. M. B., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01055-9 · Cited by 11
Russo-Savage, L., Rao, V. K. S., Eipper, B. A., & Mains, R. E. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.006 · Cited by 12
Saaoud, F., Liu, L., Xu, K., Lu, Y., Shao, Y., Issa, M., Jiang, X., Wang, X., Liu, X., Autieri, M. V., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251329583 · Cited by 13
Adak, S., Singh, S., Jain, R., Tiwari, A., Singh, B., Kumar, S., Dadhwal, A., Chakroborty, A., Sharma, A. K., Singh, R. P., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1646551 · Cited by 12
Singhaarachchi, P. H., Antal, P., Calon, F., Culmsee, C., Delpech, J.-C., Feldotto, M., Geertsema, J., Hoeksema, E. E., Kőrösi, A., Layé, S., et al. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102821 · Cited by 13
Nunes, A., Ambrósio, A. F., Castelo-Branco, M. S., & Bernardes, R. (2018) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2018.00016 · Cited by 9
Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer’s Disease
Martínez-Iglesias, O. A., Naidoo, V., Carrera, I., & Cacabelos, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052446 · Cited by 10
Pfitzer, J. C., Pinky, P. D., Perman, S., Redmon, E., Cmelak, L., Suppiramaniam, V. D., Coric, V., Qureshi, I., Gramlich, M. W., & Reed, M. N. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16215 · Cited by 8
Zhou, X., Du, K., Mao, T., Wang, N., Zhang, L., Tian, Y., Liu, T., Wang, L., & Wang, X. (2024) · iScience · doi:10.1016/j.isci.2024.111413 · Cited by 8
The 3xTg-AD Mouse Model: A Comprehensive Tool for Understanding Alzheimer’s Disease
Pattanayak, A., & Firdous, S. M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01655-w · Cited by 13
Dong, Y., Xiao, X., Zhuang, X., Wu, W., Wang, Z.-Y., Zhang, S., Li, J.-T., Zhang, K., Fu, W.-Y., Chen, J., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01667-x · Cited by 8
Characterization of the retinal changes of the 3×Tg-AD mouse model of Alzheimer’s disease
Ferreira, H. R. L., Martins, J., Nunes, A., Moreira, P. I., Castelo-Branco, M. S., Ambrósio, A. F., Serranho, P., & Bernardes, R. (2020) · Health and Technology · doi:10.1007/s12553-020-00413-w · Cited by 8
Timing impairments in early Alzheimer’s disease: Evidence from a mouse model.
Armstrong, P., Pardon, M., & Bonardi, C. (2020) · Behavioral Neuroscience · doi:10.1037/bne0000359 · Cited by 7
Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer's disease.
Liu, Y., Xu, Y.-P., Li, M.-Z., Pan, D., Li, Y.-Q., Wang, Y., Wang, L.-Z., Wu, Q., & Yang, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134938 · Cited by 8
Britz, J., Ojo, E. A., Dhukhwa, A., Saito, T., Saido, T. C., Hascup, E. R., Hascup, K. N., & Tischkau, S. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210629 · Cited by 8
Hsu, C.-H., Wang, S.-E., Lin, C.-L., Hsiao, C.-J., Sheu, S., & Wu, C. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/1939052 · Cited by 8
Animal Models of Alzheimer’s Disease
Amram, S., & Frenkel, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00003-x · Cited by 8
Adiponectin improves amyloid‐β 31‐35‐induced circadian rhythm disorder in mice
Yuan, Y., Li, C., Guo, S., Sun, C., Ning, N., Hao, H., Wang, L., Bian, Y., Liu, H., & Wang, X. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16932 · Cited by 8
Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer’s Disease Mice
Frame, G., Schuller, A. J., Smith, M. A., Crish, S. D., & Crish, S. D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220016 · Cited by 8
Yamamoto, S., Ooshima, Y., Nakata, M., Yano, T., Matsuoka, K., Watanabe, S., Maeda, R., Takahashi, H., Takeyama, M., Matsumoto, Y., et al. (2012) · Transgenic Research · doi:10.1007/s11248-012-9651-x · Cited by 7
Animal Models of Acquired Epilepsy and Tauopathies
Zheng, P., Shultz, S. R., Hovens, C. M., & O'Brien, T. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00072-9 · Cited by 7
Hall, S. E., White, Z. J., Rohn, T. T., Sudasinghe, K., & Young, M. E. (2025) · Brain Sciences · doi:10.3390/brainsci15060631 · Cited by 6
Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin
Guillot, S. J., Luppi, P., Dupuis, L., & Bolborea, M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70085 · Cited by 6
Lin, N., Goh, A., Lin, S., Chuang, K., Chang, C.-H., Li, M., Lu, C.-H., Chen, W., Wei, P.-H., Pan, I.-H., et al. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220056 · Cited by 6
Egan, K. J., & Macleod, M. R. (2014) · Clinical Investigation · doi:10.4155/cli.14.55 · Cited by 7
Baeta-Corral, R., la Fuente, M. D., & Giménez‐Llort, L. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114189 · Cited by 7
Signature of paraoxonases in the altered redox homeostasis in Alzheimer's disease
Beggiato, S., Ferrara, F., Romani, A., Cassano, T., Trentini, A., Valacchi, G., Cervellati, C., & Ferraro, L. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110839 · Cited by 6
M’Bra, P. E. H., Hamilton, L. K., Moquin‐Beaudry, G., Mangahas, C. L., Pratesi, F., Castonguay, A., Mailloux, S., Galoppin, M., Lopez, J. A., Bernier, M., et al. (2025) · Brain · doi:10.1093/brain/awaf267 · Cited by 5
rTMS Modulation of Behavioral and Biological Measures in 3xTg-AD Mice
Kraybill, E. P., Mojabi, F. S., Heath, A. M., Spikes, C. R., Beard, C., & McNerney, M. W. (2024) · Brain Sciences · doi:10.3390/brainsci14121186 · Cited by 5
VandeVrede, L. A., Abdelhamid, R. E., Qin, Z., Choi, J. W., Piyankarage, S. C., Luo, J., Larson, J., Bennett, B. M., & Thatcher, G. R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070740 · Cited by 5
Alzheimer's Disease: From Animal Models to the Human Syndrome
Orta‐Salazar, E., Vargas-Rodríguez, I., Castro-Chavira, S. A., Feria‐Velasco, A., & Díaz-Cintra, S. Y. (2016) · InTech eBooks · doi:10.5772/64619 · Cited by 6
Sleep is bi-directionally modified by amyloid beta oligomersPreprint
Özcan, G. G., Lim, S., Leighton, P. L. A., Allison, W. T., & Rihel, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/610014 · Cited by 5
Enabling systemic identification and functionality profiling for Cdc42 homeostatic modulators
Malasala, S., Azimian, F., Chen, Y., Twiss, J. L., Boykin, C., Akhtar, S. N., & Lu, Q. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01352-7 · Cited by 4
Papay, R. S., Stauffer, S. R., & Perez, D. M. (2023) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2023.100160 · Cited by 4
Models of Dementia: an introductory overview
Graham, L., & Sutherland, C. D. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390851 · Cited by 4
Abnormal whisker movements in the 3xTg‐AD mouse model of Alzheimer's disease
Simanaviciute, U., Brown, R. E., Wong, A. A., Fertan, E., & Grant, R. A. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12813 · Cited by 4
Ammassari‐Teule, M. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.868473 · Cited by 4
M’Bra, P. E. H., Suárez-Uribe, I., Avino, M., Lim, E. N. K., Mayhue, M., Balthazar, P., Aumont, A., Prévost, K., Massé, É., & Fernandes, K. J. L. (2025) · Communications Biology · doi:10.1038/s42003-025-09171-9 · Cited by 3
Sarlus, H., Codita, A., Wang, X., Cedazo-Mı́nguez, Á., Schultzberg, M., & Oprica, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.005 · Cited by 3
Hu, W. H., Dai, C., Niu, J., & Iqbal, K. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220007 · Cited by 3
QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice
Fronza, M. G., Sacramento, M., Alves, D. A. C., Praticò, D., & Savegnago, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03159-w · Cited by 3
Sex-Dependent Effects of Chronic Circadian Disruption in AβPP/PS1 Mice
Britz, J., Ojo, E. A., Haque, N., Dhukhwa, A., Hascup, E. R., Hascup, K. N., & Tischkau, S. A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230089 · Cited by 2
Ott, F. W., Sichler, M. E., Bouter, C., Enayati, M., Wiltfang, J., Bayer, T. A., Beindorff, N., Löw, M. J., & Bouter, Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241306770 · Cited by 2
Chakraborty, S., Wu, P.-C., Chen, S.-T., Chiu, M., & Sun, C. (2020) · Label-free Biomedical Imaging and Sensing (LBIS) · doi:10.1117/12.2543875 · Cited by 2
Alzheimer's Disease and the Mistiming of Behavior
Sterniczuk, R., & Antle, M. C. (2015) · doi:10.1002/9781118467831.ch19 · Cited by 2
Self-citationAli, M. A., Siam, M. H. B., Vardaman, D., Bolding, C., Brazell, J. N., Whatley, A. D., Risley, C. A., Tidwell, H., Hossain, S. N., Samal, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693494 · Cited by 2
Role of Astrocytic Serine in Learning and Memory and its Implications in Alzheimer's Disease.
Maugard, M. (2018) · theses.fr (ABES) · doi:10.70675/2a0528d8zc687z43e6za9b4zfa45cdb5b6d9 · Cited by 1
Dias, O. F. M., Valle, N. M. E., Mamani, J. B., Costa, C. J. S., Alves, A. H., Oliveira, F. A., Rego, G. N. A., Galanciak, M. C. S., Felix, K., Nucci, M. P., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083657 · Cited by 2
Stress, stress systems, and Alzheimer's disease
Eberly, S. G., Phumsatitpong, C., Munro, C. E., Neylan, T. C., Kaufer, D., & Ehrenberg, A. J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71542 · Cited by 1
Stover, K. R. (2015) · DalSpace (Dalhousie University) · Cited by 1
Stover, K. R. (2012) · Library and Archives Canada (Government of Canada) · Cited by 1
Characterization of the Retinal Changes of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Ferreira, H. R. L., Martins, J., Nunes, A., Moreira, P. I., Castelo-Branco, M. S., Ambrósio, A. F., Serranho, P., & Bernardes, R. (2019) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-31635-8_220 · Cited by 1
Differences in brain regions of three mice strains identified by label-free micro-Raman
Segura-Uribe, J. J., Farfán‐García, E. D., Guerra‐Araiza, C., Ciprés-Flores, F. J., Torre, P. G.-D., & Soriano-Ursua, M. A. (2018) · Spectroscopy Letters · doi:10.1080/00387010.2018.1473883 · Cited by 1
Leonard, K., Vasylkiv, V., & Kelly, D. M. (2020) · Learning & Behavior · doi:10.3758/s13420-019-00401-9 · Cited by 1
Metadata
- Authors
- Sterniczuk, R., Antle, M. C., LaFerla, F. M., & Dyck, R. H.
- Affiliations
- University of Calgary (CA)
- University of California, Irvine (US)
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 1348
- Pages
- 149-155
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1967375871
- Cited by
- 228
- References
- 43
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 14 · 2023: 17 · 2022: 18 · 2021: 24 · 2020: 20 · 2019: 13 · 2018: 10 · 2017: 12 · 2016: 11 · 2015: 16 · 2014: 19 · 2013: 12 · 2012: 12
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NSERC
- CIHR
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- Alzheimer's disease, 3xTg-AD mice, triple transgenic mice, amyloid-beta pathology, tau pathology, cognitive impairment, behavioral deficits, anxiety, fear, startle response, freezing behavior, visuomotor coordination, muscle strength, aging
- MeSH terms
- Alzheimer Disease, Animals, Avoidance Learning, Behavioral Symptoms, Cognition Disorders, Disease Models, Animal, Exploratory Behavior, Female, Humans, Male, Mice, Inbred C57BL, Motor Activity, Neurologic Examination, Psychomotor Performance, Reaction Time, Time Factors, Amyloid beta-Protein Precursor, Statistics, Nonparametric, Maze Learning, Animals, Genetically Modified, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review